These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 12593442
1. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma. Kumar S, Wairagkar NS, Mahanta J. Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442 [Abstract] [Full Text] [Related]
2. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma. Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM. J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473 [Abstract] [Full Text] [Related]
4. [Evaluation of detection of Epstein-Barr virus Rta/IgG in nasopharyngeal carcinoma]. Zheng YM, Cain YL, Cheng JR, Li J, Mo YK, Gao JQ, Dong ZR, Zhong QY. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):285-7. PubMed ID: 20108775 [Abstract] [Full Text] [Related]
8. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland. Friborg J, Jarrett RF, Liu MY, Falk KI, Koch A, Olsen OR, Duncan P, Wohlfarht J, Chen JY, Melbye M. J Med Virol; 2007 Dec 01; 79(12):1877-81. PubMed ID: 17935169 [Abstract] [Full Text] [Related]
12. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma. Klemenc P, Marin J, Soba E, Gale N, Koren S, Strojan P. J Med Virol; 2006 Aug 01; 78(8):1083-90. PubMed ID: 16789009 [Abstract] [Full Text] [Related]
15. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. Liu MY, Chang YL, Ma J, Yang HL, Hsu MM, Chen CJ, Chen JY, Yang CS. J Med Virol; 1997 Jul 01; 52(3):262-9. PubMed ID: 9210034 [Abstract] [Full Text] [Related]
16. Cytogenetic and viral studies in nasopharyngeal carcinomas in patients of Indian origin. Kumari P, Augustus M, Naik U, Ravi V, Shenoy AM, Rao CR, Kumar RV. Indian J Cancer; 1995 Mar 01; 32(1):10-4. PubMed ID: 7558105 [Abstract] [Full Text] [Related]
17. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma. Liu MY, Huang YT, Sheen TS, Chen JY, Tsai CH. J Med Virol; 2004 Aug 01; 73(4):574-82. PubMed ID: 15221902 [Abstract] [Full Text] [Related]
18. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Cancer; 2003 Jul 15; 98(2):288-91. PubMed ID: 12872347 [Abstract] [Full Text] [Related]
19. [Development of new methods for the diagnosis of nasopharyngeal carcinoma]. Pi GH, Cheng DS, Zhou Y, Zhang WL. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb 15; 24(1):65-7. PubMed ID: 20848856 [Abstract] [Full Text] [Related]
20. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma. Mai S, Zong Y, Zhang M, Zhong B, Lin S. Chin Med J (Engl); 2002 Dec 15; 115(12):1895-7. PubMed ID: 12622949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]